Kentucky 2025 Regular Session

Kentucky House Bill HB501 Latest Draft

Bill / Enrolled Version

                            UNOFFICIAL COPY  	25 RS HB 501/EN 
Page 1 of 1 
HB050120.100 - 1362 - XXXX   3/28/2025 2:52 PM  	Engrossed 
AN ACT relating to pharmaceutical drugs. 1 
Be it enacted by the General Assembly of the Commonwealth of Kentucky: 2 
SECTION 1.   A NEW SECTION OF KRS CHAPTER 315 IS CREATED TO 3 
READ AS FOLLOWS: 4 
(1) Notwithstanding any other provision of law to the contrary, when a pharmacist is 5 
aware that a practitioner has died, a prescription issued by that practitioner may 6 
continue to be dispensed based on the pharmacist's professional judgment and no 7 
later than one hundred eighty (180) days following the date on which the 8 
practitioner died. 9 
(2) Nothing in this section authorizes the dispensing of a prescription that was issued 10 
for a controlled substance unless permitted under the federal Controlled 11 
Substances Act and regulations of the United States Drug Enforcement 12 
Administration. 13 
Section 2.   2025 RS HB 495/VO, Section 1, is amended to read as follows: 14 
Notwithstanding any provision of law to the contrary and unless required under federal 15 
law, the Department for Medicaid Services and any managed care organization with 16 
whom the department contracts for the delivery of Medicaid services are hereby 17 
prohibited from expending any Medicaid funds on any of the following: 18 
(1) Cross-sex hormones when prescribed or administered primarily or solely for the 19 
treatment of gender dysphoria[in amounts greater than would normally be 20 
produced endogenously in a healthy person of the same age and sex]; and 21 
(2) Gender reassignment surgery to alter or remove physical or anatomical 22 
characteristics or features that are typical for and characteristic of a person's 23 
biological sex. 24